Twenty (42.6%) developed critical illness hyperglycemia, defined as persistent BG levels >140 mg/dL (7.7 mmol/L), and received insulin via our published pediatric-specific hyperglycemia protocol [14,15]. This evidence concerns the gene INS and Hyperglycemia.